본문으로 건너뛰기
← 뒤로

Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights.

American journal of nephrology 2026 Vol.57(2) p. 180-192

Royal V, Leung N, Karam S, Bridoux F, Nasr SH

📝 환자 설명용 한 줄

[BACKGROUND] Paraneoplastic glomerular diseases are triggered by substances secreted by tumor cells, such as tumor antigens, rather than direct tumor invasion.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Royal V, Leung N, et al. (2026). Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights.. American journal of nephrology, 57(2), 180-192. https://doi.org/10.1159/000546050
MLA Royal V, et al.. "Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights.." American journal of nephrology, vol. 57, no. 2, 2026, pp. 180-192.
PMID 40267904
DOI 10.1159/000546050

Abstract

[BACKGROUND] Paraneoplastic glomerular diseases are triggered by substances secreted by tumor cells, such as tumor antigens, rather than direct tumor invasion.

[SUMMARY] These conditions frequently manifest as glomerular disorders, particularly in the elderly, with membranous nephropathy being the most observed lesion. They often present with proteinuria, hematuria, and/or varying levels of kidney dysfunction. In some cases, the initial presentation may precede the diagnosis of malignancy and can be indistinguishable from the idiopathic glomerulopathies, requiring a high level of clinical suspicion to accurately identify a paraneoplastic origin. Although the exact pathophysiologic mechanisms underlying paraneoplastic glomerulopathy are not fully understood, they are thought to involve an immune-mediated response to tumor antigens in most cases.

[KEY MESSAGE] Recognizing paraneoplastic glomerulopathies is of significant clinical importance as their management is distinct and has substantial implications for the treatment of the associated malignancy.

MeSH Terms

Humans; Paraneoplastic Syndromes; Glomerulonephritis, Membranous; Kidney Glomerulus; Antigens, Neoplasm; Glomerulonephritis